Immunomodulatory properties of vitamins, flavonoids and plant oils and their potential as vaccine adjuvants and delivery systems

Expert Opinion on Biological Therapy

Volumn 11, Issue 11, 2011, Pages 1501-1513

  Vajdy, Michael ^a  

^a EpitoGenesis Inc   (United States)

Author keywords

Adjuvant; Delivery system; Flavonoids; Mucosal; Nutritive; Safety; Vaccine; Vegetable oil; Vitamin A; Vitamin C; Vitamin D; Vitamin E

Indexed keywords

ADJUVANT; ALPHA TOCOPHEROL; ARACHIS OIL; ASCORBIC ACID; CHITOSAN; CHOLERA VACCINE; COLECALCIFEROL; DAIDZEIN; FLAVONOID; GENISTEIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INFLUENZA VACCINE; KAEMPFEROL; LIPOPOLYSACCHARIDE; MIFAMURTIDE; NEWCASTLE DISEASE VACCINE; PHOSPHORYL LIPID A; PHYTOL; POLYPHENOL DERIVATIVE; QUERCETIN; RETINOL; SAPONIN; SOYBEAN OIL EMULSION; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; VACCINE; VEGETABLE OIL; VITAMIN; VITAMIN D;

ADJUVANT THERAPY; BRASSICA; BRASSICA ALBA; BRASSICA NIGRA; CAPSICUM MINIMUM; CELLULAR IMMUNITY; CHICKEN; COCHLEARIA ARMORACIA; CYTOKINE PRODUCTION; DNA IMMUNIZATION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG STRUCTURE; ESCHERICHIA COLI; EUGENIA CARYPHYLLUS; GARLIC; GINGER; HORSERADISH; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; LEGIONELLA PNEUMOPHILA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUTRITIVE IMMUNE ENHANCING DELIVERY SYSTEM; OSTEOARTHRITIS; REVIEW; ROSEMARY; RUTACEAE; TUBERCULOSIS; URTICA DIOICA; VACCINATION; VIBRIO CHOLERAE; VITAMIN DEFICIENCY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DRUG DELIVERY SYSTEMS; FLAVONOIDS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOLOGIC FACTORS; PLANT OILS; VACCINES; VITAMINS;

BACTERIA (MICROORGANISMS);

EID: 80053644600     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2011.623695     Document Type: Review

References (98)

1. Dudas RA, Karron RA. Respiratory syncytial virus vaccines. Clin Microbiol Rev 1998;11:430-9 (Pubitemid 28379093)
2. Kirk DD, Rempel R, Pinkhasov J, et al. Application of Quillaja saponaria extracts as oral adjuvants for plant-made vaccines. Expert Opin Biol Ther 2004;4:947-58 (Pubitemid 38843231)
3. Schultze V, D'Agosto V, Wack A, et al. Safety of MF59 adjuvant. Vaccine 2008;26:3209-22
4. Pellegrini M, Nicolay U, Lindert K, et al. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. Vaccine 2009;27:6959-65
5. Keitel W, Groth N, Lattanzi M, et al. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. Vaccine 2010;28:840-8
6. Smith JW, Fletcher WB, Peters M, et al. Response to influenza vaccine in adjuvant 65-4. J Hyg (Lond) 1975;74:251-9
7. Willson PJ, Rossi-Campos A, Potter AA. Tissue reaction and immunity in swine immunized with Actinobacillus pleuropneumoniae vaccines. Can J Vet Res 1995;59:299-305
8. Eghafona NO. Immune responses following cocktails of inactivated measles vaccine and Arachis hypogaea L. (groundnut) or Cocos nucifera L. (coconut) oils adjuvant. Vaccine 1996;14:1703-6
9. Audibert F, Chedid L. Increase of immune response by administration of metabolizable vegetable oil emulsions. C R Acad Sci Hebd Seances Acad Sci D 1975;280:1629-32
10. Roy P, Venugopalan AT, Koteeswaran A. Efficacy of live adjuvanted mesogenic Newcastle disease vaccine in chickens. Vaccine 1999;17:2674-6 (Pubitemid 29314464)
11. Bielinska AU, Chepurnov AA, Landers JJ, et al. A novel, killed-virus nasal vaccinia virus vaccine. Clin Vaccine Immunol 2008;15:348-58 (Pubitemid 352025538)
12. Hamouda T, Chepurnov A, Mank N, et al. Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model. Hum Vaccin 2010;6:585-94
13. Makidon PE, Bielinska AU, Nigavekar SS, et al. Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine. PLoS One 2008;3:e2954
14. Bielinska AU, Janczak KW, Landers JJ Jr, et al. Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2008;24:271-81 (Pubitemid 351282102)
15. Lim SY, Bauermeister A, Kjonaas RA, et al. Phytol-based novel adjuvants in vaccine formulation: Assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice. J Immune Based Ther Vaccines 4:5
16. Sakuma S, Atsumi K, Kikukawa K. Transdermal and transmucosal preparations. US20070166362; 2007
17. Vajdy M, Padrah S. Adjuvant compositions and methods of use. US20100172941; 2010
18. Romanowski F, Klenk H. Thiocyanates and Isothiocyanates, Organic. In: Ullmanns Encyclopedia of Industrial Chemistry. Wiley-VCH; Weinheim: 2005
19. Mason L, Moore RA, Edwards JE, et al. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ 2004;328(7446):995
20. Louis SM, Jamieson A, Russell NJ, et al. The role of substance P and calcitonin gene-related peptide in neurogenic plasma extravasation and vasodilatation in the rat. Neuroscience 1989;32:581-6 (Pubitemid 20008288)
21. Inoue H, Asaka T, Nagata N, et al. Mechanism of mustard oil-induced skin inflammation in mice. Eur J Pharmacol 1997;333:231-40 (Pubitemid 27387396)
22. Banvolgyi A, Pozsgai G, Brain SD, et al. Mustard oil induces a transient receptor potential vanilloid 1 receptor-independent neurogenic inflammation and a non-neurogenic cellular inflammatory component in mice. Neuroscience 2004;125:449-59 (Pubitemid 38446750)
23. Darmstadt GL, Saha SK. Neonatal oil massage. Indian Pediatr 2003;40:1098-9
24. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999;12:564-82 (Pubitemid 29484747)
25. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000;130:2073S-85S (Pubitemid 30619386)
26. Wang J, Mazza G. Effects of anthocyanins and other phenolic compounds on the production of tumor necrosis factor alpha in LPS/IFN-gamma-activated RAW 264.7 macrophages. J Agric Food Chem 2002;50:4183-9 (Pubitemid 34756012)
27. Hirano T, Higa S, Arimitsu J, et al. Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. Int Arch Allergy Immunol 2004;134:135-40 (Pubitemid 38716259)
28. Miller MJ, Angeles FM, Reuter BK, et al. Dietary antioxidants protect gut epithelial cells from oxidant-induced apoptosis. BMC Complement Altern Med 2001;1:11
29. Nair N, Mahajan S, Chawda R, et al. Grape seed extract activates Th1 cells in vitro. Clin Diagn Lab Immunol 2002;9:470-6 (Pubitemid 34226048)
30. Matsunaga K, Klein TW, Friedman H, et al. Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins. Infect Immun 2001;69:3947-53 (Pubitemid 32493317)
31. Yamamoto Y, Matsunaga K, Friedman H. Protective effects of green tea catechins on alveolar macrophages against bacterial infections. Biofactors 2004;21:119-21 (Pubitemid 40921837)
32. Kang TH, Lee JH, Song CK, et al. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res 2007;67:802-11
33. Mantena SK, Roy AM, Katiyar SK. Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors. Photochem Photobiol 2005;81:1174-9 (Pubitemid 41545942)
34. Ahmed S, Rahman A, Hasnain A, et al. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 2002;33:1097-105
35. Kawai K, Tsuno NH, Kitayama J, et al. Epigallocatechin gallate induces apoptosis of monocytes. J Allergy Clin Immunol 2005;115:186-91 (Pubitemid 40075441)
36. Fujimura Y, Tachibana H, Yamada K. Lipid raft-associated catechin suppresses the FcepsilonRI expression by inhibiting phosphorylation of the extracellular signal-regulated kinase1/2. FEBS Lett 2004;556:204-10 (Pubitemid 38058580)
37. Katiyar SK, Mukhtar H. Green tea polyphenol (-)-epigallocatechin-3- gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J Leukoc Biol 2001;69:719-26 (Pubitemid 32466409)
38. Katiyar SK, Bergamo BM, Vyalil PK, Elmets CA. Green tea polyphenols: DNA photodamage and photoimmunology. J Photochem Photobiol B 2001;65:109-14 (Pubitemid 34110725)
39. Katiyar SK, Challa A, McCormick TS. Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallocatechin-3- gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogenesis 1999;20:2117-24 (Pubitemid 29535313)
40. Varilek GW, Yang F, Lee EY, et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 2001;131:2034-9 (Pubitemid 32661076)
41. Haqqi TM, Anthony DD, Gupta S, et al. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci USA 1999;96:4524-9 (Pubitemid 29190369)
42. Stephensen CB. Vitamin A, infection, and immunity. Annu Rev Nutr 2001;21:167-92
43. Villamor E, Fawzi WW. Effects of vitamin A supplementation on immune responses and correlation with nutritional outcome. Clin Microbiol Rev 2005;18:446-64 (Pubitemid 40995111)
44. Jason J, Archibald LK, Nwanyanwu OC, et al. Vitamin A levels and immunity in humans. Clin Diagn Lab Immunol 2002;9:616-21 (Pubitemid 34538223)
45. Ross AC. Addressing research questions with national survey data-the relation of vitamin A status to infection and inflammation. Am J Clin Nutr 2000;72:1069-70
46. Benn CS, Aaby P, Nielsen J, et al. Does vitamin A supplementation interact with routine vaccinations? An analysis of the Ghana Vitamin A supplementation trial. Am J Clin Nutr 2009;90:629-39
47. Newton S, Owusu-Agyei S, Ampofo W, et al. Vitamin A supplementation enhances infants' immune responses to hepatitis B vaccine but does not affect responses to Haemophilus influenzae type B vaccine. J Nutr 2007;137:1272-7 (Pubitemid 46701922)
48. Diness BR, Fisker AB, Roth A, et al. Effect of high dose vitamin A supplementation on the immune response to Bacille Calmette Guerin vaccine. Am J Clin Nutr 2007;86:1152-9 (Pubitemid 47538321)
49. Ross AC. Vitamin A supplementation and retinoic acid treatment in the regulation of antibody responses in vivo. Vitam Horm 2007;75:197-222
50. Ma Y, Ross AC. The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid. Proc Natl Acad Sci USA 2005;102:13556-61 (Pubitemid 41420887)
51. Yu S, Xia M, Xu W, et al. All-trans retinoic acid biases immune response induced by DNA vaccine in a Th2 direction. Vaccine 2005;23:5160-7 (Pubitemid 41356546)
52. Furugaki K, Pokorna K, Le Pogam C, et al. DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model. Blood 2010;115:653-6
53. Yamada H, Mizuno S, Ross AC, et al. Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected with Mycobacterium tuberculosis. J Nutr 2007;137:2696-700 (Pubitemid 350255300)
54. Kurata T, Micksche M. Suppressed tumor growth and metastasis by vitamin A + BCG in Lewis lung tumor bearing mice. Oncology 1977;34:212-15 (Pubitemid 8208271)
55. Athanassiades T. Adjuvant effect of vitamin A palmitate and analogs on cell-mediated immunity. J Natl Cancer Inst 1981;67:1153-6 (Pubitemid 12252107)
56. Wiedermann U, Hanson LA, Holmgren J, et al. Impaired mucosal antibody response to cholera toxin in vitamin A-deficient rats immunized with oral cholera vaccine. Infect Immun 1993;61:3952-7 (Pubitemid 23260072)
57. Saurer L, McCullough KC, Summerfield A. In vitro induction of mucosa-type dendritic cells by all-trans retinoic acid. J Immunol 2007;179:3504-14
58. Mucida D, Park Y, Kim G, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317:256-60 (Pubitemid 47076203)
59. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007;204:1757-64 (Pubitemid 47236314)
60. Benson MJ, Pino-Lagos K, Rosemblatt M, et al. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007;204:1765-74 (Pubitemid 47236315)
61. Sun CM, Hall JA, Blank RB, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007;204:1775-85 (Pubitemid 47236316)
62. Kang SG, Lim HW, Andrisani OM, et al. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol 2007;179:3724-33
63. Monteleone G, Pallone F, MacDonald TT. Smad7 in TGF-beta-mediated negative regulation of gut inflammation. Trends Immunol 2004;25:513-17 (Pubitemid 39208348)
64. Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor-beta1 gene results in multifocal inflammatory disease. Nature 1992;359:693-9
65. Mucida D, Cheroutre H. TGFbeta and retinoic acid intersect in immune-regulation. Cell Adhes Migr 2007;1:142-4
66. Yu M, Vajdy M. A novel retinoic acid, catechin hydrate and mustard oil-based emulsion for enhanced cytokine and antibody responses against multiple strains of HIV-1 following mucosal and systemic vaccinations. Vaccine 2011;29:2429-36
67. Chen Q, Ross AC. Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4. Cell Immunol 2007;249:37-45
68. Ballow M, Wang W, Xiang S. Modulation of B-cell immunoglobulin synthesis by retinoic acid. Clin Immunol Immunopathol 1996;80:S7-S81
69. Anderson TW, Reid DB, Beaton GH. Vitamin C and the common cold. Can Med Assoc J 1973;108:133
70. Anderson TW, Suranyi G, Beaton GH. The effect on winter illness of large doses of vitamin C. Can Med Assoc J 1974;111:31-6
71. Vitamin C and the common cold. Br Med J 1976;1(6010):606-7
72. Wilson CWM, Loh HS. Vitamin C and colds. Lancet 1973;1:1058-9
73. Banic S. Immunostimulation by vitamin C. Int J Vitam Nutr Res Suppl 1982;23:49-52
74. Prinz W, Bloch G, Gilich G, et al. A systematic study of the effect of vitamin C supplementation on the humoral immune response in ascorbic-dependent mammals. Int J Vitam Nutr Res 1980;50:294-300
75. Amakye-Anim J, Lin TL, Hester PY, et al. Ascorbic acid supplementation improved antibody response to infectious bursal disease vaccination in chickens. Poult Sci 2000;79:680-8
76. Pardue SL, Thaxton JP, Brake J. Role of ascorbic acid in chickens exposed to high environmental temperature. J Appl Physiol 1985;58:1511-16 (Pubitemid 15027049)
77. Rund B. Vitamin C plays a role in immunity. Poult Dig 1989;48:44-55
78. Ganguly R, Park J. Immunostimulating agents against influenza virus infection in senescent rats. Allerg Immunol (Leipz) 1988;34:239-47 (Pubitemid 19035609)
79. Stankova L, Gerherdt NB, Nagel L, et al. Ascorbate and phagocyte function. Infect Immun 1975;12:252-5
80. Thomas WR, Holt PG. Vitamin C and immunity: an assessment of the evidence. Clin Exp Immunol 1978;32:370-9 (Pubitemid 8360026)
81. McCorkle FR, Taylor R, Stinson E, et al. The effects of mega levels of vitamin C on the immune response of the chicken. Poultry Sci 1980;59:1324-7
82. Ivanov AP, Dragunsky EM, Chumakov KM. 1,25-dihydroxyvitamin D3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice. J Infect Dis 2006;193:598-600 (Pubitemid 43202752)
83. Van der Stede Y, Cox E, Van den broeck W, et al. Enhanced induction of the IgA response in pigs by calcitriol after intramuscular immunization. Vaccine 2001;19:1870-8 (Pubitemid 32178334)
84. Enioutina EY, Visic D, Daynes RA. The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity. Vaccine 2000;18:2753-67 (Pubitemid 30211584)
85. Enioutina EY, Visic VD, Daynes RA. Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants. Vaccine 2000;18:2381-93 (Pubitemid 30156809)
86. McMurray DN, Bartow RA, Mintzer CL, et al. Micronutrient status and immune function in tuberculosis. Ann NY Acad Sci 1990;587:59-69 (Pubitemid 20249265)
87. Ramanathapuram LV, Hahn T, Graner MW, et al. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines. Cancer Immunol Immunother 2006;55:166-77 (Pubitemid 41682588)
88. Tomasetti M, Neuzil J. Vitamin E analogues and immune response in cancer treatment. Vitam Horm 2007;76:463-91
89. Franchini A, Bertuzzi S, Tosarelli C, et al. Vitamin E in viral inactivated vaccines. Poult Sci 1995;74:666-71
90. Franchini A, Canti M, Manfreda G, et al. Vitamin E as adjuvant in emulsified vaccine for chicks. Poult Sci 1991;70:1709-15
91. Hogan JS, Weiss WP, Smith KL, et al. Vitamin E as an Adjuvant in an Escherichia coli J5 Vaccine. J Dairy Sci 1993;76:401-7
92. Hogan JS, Smith KL, Weiss WP, et al. Relationships among vitamin E, selenium, and bovine blood neutrophils. J Dairy Sci 1990;73:2372-8
93. Hogan JS, Weiss WP, Todhunter DA, et al. Bovine neutrophil responses to parenteral vitamin E. J Dairy Sci 1992;75:399-405
94. Afzal M, Tengerdy RP, Ellis RP, et al. Protection of rams against epididymitis by a Brucela ovis-vitamin E adjuvant vaccine. Vet Immunol Immunopathol 1984;7:293-304 (Pubitemid 16157112)
95. Tengerdy RP, Meyer DL, Lauerman LH, et al. Vitamin E-enhanced humoral antibody response to Clostridium perfringens type D in sheep. Br Vet J 1983;139:147-52 (Pubitemid 13080243)
96. Tengerdy RP, Lacetera NG. Vitamin E adjuvant formulations in mice. Vaccine 1991;9:204-6
97. Morel S, Didierlaurent A, Bourguignon P, et al. Adjuvant System AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity. Vaccine 2011;29:2461-73
98. Tengerdy RP. The role of vitamin E in immune response and disease resistance. Ann NY Acad Sci 1990;587:24-33 (Pubitemid 20249261)